Literature DB >> 18702608

Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia.

Bouke C de Jong1, Philip C Hill, Alex Aiken, Timothy Awine, Martin Antonio, Ifedayo M Adetifa, Dolly J Jackson-Sillah, Annette Fox, Kathryn Deriemer, Sebastien Gagneux, Martien W Borgdorff, Keith P W J McAdam, Tumani Corrah, Peter M Small, Richard A Adegbola.   

Abstract

BACKGROUND: There is considerable variability in the outcome of Mycobacterium tuberculosis infection. We hypothesized that Mycobacterium africanum was less likely than M. tuberculosis to transmit and progress to tuberculosis disease.
METHODS: In a cohort study of patients with tuberculosis and their household contacts in The Gambia, we categorized 1808 HIV-negative tuberculosis contacts according to exposure to M. tuberculosis or M. africanum. Positive skin test results indicated transmission, and development of tuberculosis during 2 years of follow-up indicated progression to disease.
RESULTS: Transmission rates were similar, but rates of progression to disease were significantly lower in contacts exposed to M. africanum than in those exposed to M. tuberculosis (1.0% vs. 2.9%; hazard ratio [HR], 3.1 [95% confidence interval {CI}, 1.1-8.7]). Within M. tuberculosis sensu stricto, contacts exposed to a Beijing family strain were most likely to progress to disease (5.6%; HR relative to M. africanum, 6.7 [95% CI, 2.0-22]).
CONCLUSIONS: M. africanum and M. tuberculosis transmit equally well to household contacts, but contacts exposed to M. africanum are less likely to progress to tuberculosis disease than those exposed to M. tuberculosis. The variable rate of progression by lineage suggests that tuberculosis variability matters in clinical settings and should be accounted for in studies evaluating tuberculosis vaccines and treatment regimens for latent tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702608      PMCID: PMC2597014          DOI: 10.1086/591504

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains.

Authors:  Anthony G Tsolaki; Aaron E Hirsh; Kathryn DeRiemer; Jose Antonio Enciso; Melissa Z Wong; Margaret Hannan; Yves-Olivier L Goguet de la Salmoniere; Kumiko Aman; Midori Kato-Maeda; Peter M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

Review 2.  Mycobacterium bovis infection in human beings.

Authors:  J M Grange
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

3.  Risk factors for positive tuberculin skin test in Guinea-Bissau.

Authors:  Per Gustafson; Ida Lisse; Victor Gomes; Cesaltina S Vieira; Christian Lienhardt; Anders Nauclér; Henrik Jensen; Peter Aaby
Journal:  Epidemiology       Date:  2007-05       Impact factor: 4.822

4.  A new evolutionary scenario for the Mycobacterium tuberculosis complex.

Authors:  R Brosch; S V Gordon; M Marmiesse; P Brodin; C Buchrieser; K Eiglmeier; T Garnier; C Gutierrez; G Hewinson; K Kremer; L M Parsons; A S Pym; S Samper; D van Soolingen; S T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion.

Authors:  Lian-Yong Gao; Su Guo; Bryant McLaughlin; Hiroshi Morisaki; Joanne N Engel; Eric J Brown
Journal:  Mol Microbiol       Date:  2004-09       Impact factor: 3.501

Review 6.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

7.  Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.

Authors:  Alexander S Pym; Priscille Brodin; Laleh Majlessi; Roland Brosch; Caroline Demangel; Ann Williams; Karen E Griffiths; Gilles Marchal; Claude Leclerc; Stewart T Cole
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

8.  A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes.

Authors:  B López; D Aguilar; H Orozco; M Burger; C Espitia; V Ritacco; L Barrera; K Kremer; R Hernandez-Pando; K Huygen; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

9.  Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia.

Authors:  R A Adegbola; P Hill; I Baldeh; J Otu; R Sarr; J Sillah; C Lienhardt; T Corrah; K Manneh; F Drobniewski; K P W J McAdam
Journal:  Int J Tuberc Lung Dis       Date:  2003-04       Impact factor: 2.373

10.  Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program.

Authors:  Martin I Voskuil; Dirk Schnappinger; Kevin C Visconti; Maria I Harrell; Gregory M Dolganov; David R Sherman; Gary K Schoolnik
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

View more
  148 in total

1.  Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali.

Authors:  Amadou Kone; Bassirou Diarra; Keira Cohen; Seydou Diabate; Bourahima Kone; Mahamane T Diakite; Hawa Diarra; Moumine Sanogo; Antieme C G Togo; Yeya Dit Sadio Sarro; Bocar Baya; Nadie Coulibaly; Ousmane Kodio; Chad J Achenbach; Robert L Murphy; Jane L Holl; Sophia Siddiqui; Seydou Doumbia; William R Bishai; Souleymane Diallo; Mamoudou Maiga
Journal:  HLA       Date:  2019-01-02       Impact factor: 4.513

2.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

3.  Mycobacterium tuberculosis lineage--what's in your lungs?

Authors:  Midori Kato-Maeda; Payam Nahid
Journal:  Clin Infect Dis       Date:  2012-01-15       Impact factor: 9.079

4.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

5.  Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio) Mycobacterium tuberculosis sublineage.

Authors:  Scott A Weisenberg; Andrea L Gibson; Richard C Huard; Natalia Kurepina; Heejung Bang; Luiz C O Lazzarini; Yalin Chiu; Jiehui Li; Shama Ahuja; Jeff Driscoll; Barry N Kreiswirth; John L Ho
Journal:  Infect Genet Evol       Date:  2011-08-02       Impact factor: 3.342

6.  Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.

Authors:  Bas C Mourik; Gerjo J de Knegt; Annelies Verbon; Johan W Mouton; Hannelore I Bax; Jurriaan E M de Steenwinkel
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 7.  Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.

Authors:  Hansong Chae; Sung Jae Shin
Journal:  J Microbiol       Date:  2018-05-02       Impact factor: 3.422

8.  Mycobacterium tuberculosis of the RDRio genotype is the predominant cause of tuberculosis and associated with multidrug resistance in Porto Alegre City, South Brazil.

Authors:  Elis Regina Dalla Costa; Luiz Claudio Oliveira Lazzarini; Paulo Fernado Perizzolo; Chyntia Acosta Díaz; Fernanda S Spies; Lucas Laux Costa; Andrezza W Ribeiro; Caroline Barroco; Sandra Jungblut Schuh; Marcia Aparecida da Silva Pereira; Claudia F Dias; Harrison M Gomes; Gisela Unis; Arnaldo Zaha; Pedro E Almeida da Silva; Philip N Suffys; Maria L R Rossetti
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

9.  Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update.

Authors:  Bouke C de Jong; Ifedayo Adetifa; Brigitte Walther; Philip C Hill; Martin Antonio; Martin Ota; Richard A Adegbola
Journal:  FEMS Immunol Med Microbiol       Date:  2009-11-03

10.  How well do you know your monkey TB model?

Authors:  G Engel; A K Wilbur; L Jones-Engel
Journal:  J Med Primatol       Date:  2012-12-15       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.